| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| DELPHI UNTERNEHMENSBERATUNG AKTIENGESELLSCHAFT | 10%+ Owner | ZIEGELHAUSER LANDSTRASSE 3, HEIDELBERG, GERMANY | By: /s/ Martin Flick, attorney in fact for Delphi Unternehmensberatung Aktiengesellschaft | 30 Sep 2025 | 0001571070 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | BFRI | Common Stock | 400,000 | 16 Sep 2025 | By Biofrontera AG | F1 | |||||
| holding | BFRI | Common Stock | 58,884 | 16 Sep 2025 | By Deutsche Balaton Aktiengesellschaft | F2 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | BFRI | Series D Convertible Preferred Stock | 16 Sep 2025 | Common Stock | 4,831,172 | $0.6249 | By Biofrontera AG | F1, F3 |
| Id | Content |
|---|---|
| F1 | The reported shares are held directly by Biofrontera AG. The Reporting Person and its affiliates collectively hold approximately 62.2% of the outstanding voting stock of Biofrontera AG and therefore may be deemed to beneficially own the shares owned by Biofrontera AG. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| F2 | The reported shares are held directly by Deutsche Balaton Aktiengesellschaft. The Reporting Person owns a majority interest in VV Beteiligungen Aktiengesellschaft, which owns a majority interest in Deutsche Balaton Aktiengesellschaft. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its indirect pecuniary interest therein, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose. |
| F3 | The convertible preferred stock is convertible at any time at the holder's option, subject to a limitation that prevents the holder and its affiliates from beneficially owning more than 19.99% of the outstanding common stock upon conversion. The preferred stock has no expiration date. |